Novo Nordisk Financial Overview
Novo Nordisk's market cap is currently €189.93B. The company's EPS TTM is €0.5934288598299999; its P/E ratio is 13.61; Novo Nordisk is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €0.77. See an overview of income statement, balance sheet, and cash flow financials.
